Your browser doesn't support javascript.
loading
Small cell osteosarcoma versus fusion-driven round cell sarcomas of bone: retrospective clinical, radiological, pathological, and (epi)genetic comparison with clinical implications.
Hiemcke-Jiwa, Laura S; Sumathi, Vaiyapuri P; Baumhoer, Daniel; Smetsers, Stephanie E; Haveman, Lianne M; van Noesel, Max M; van Langevelde, Kirsten; Cleven, Arjen H G; van de Sande, Michiel A J; Ter Horst, Simone A J; Kester, Lennart A; Flucke, Uta.
  • Hiemcke-Jiwa LS; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands. L.S.Jiwa-3@prinsesmaximacentrum.nl.
  • Sumathi VP; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. L.S.Jiwa-3@prinsesmaximacentrum.nl.
  • Baumhoer D; The Royal Orthopaedic Hospital NHS Foundation Trust, Birmingham, UK.
  • Smetsers SE; Bone Tumor Reference Centre, Institute of Pathology, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Haveman LM; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • van Noesel MM; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • van Langevelde K; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Cleven AHG; Division Imaging & Cancer, University Medical Center Utrecht, Utrecht, The Netherlands.
  • van de Sande MAJ; Department of Radiology, University Medical Center Leiden, Leiden, The Netherlands.
  • Ter Horst SAJ; Department of Pathology, University Medical Center Groningen, Groningen, The Netherlands.
  • Kester LA; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Flucke U; Department of Orthopedic Surgery, University Medical Center Leiden, Leiden, The Netherlands.
Virchows Arch ; 484(3): 451-463, 2024 Mar.
Article en En | MEDLINE | ID: mdl-38332052
ABSTRACT
Small cell osteosarcoma (SCOS), a variant of conventional high-grade osteosarcoma (COS), may mimic fusion-driven round cell sarcomas (FDRCS) by overlapping clinico-radiological and histomorphological/immunohistochemical characteristics, hampering accurate diagnosis and consequently proper therapy. We retrospectively analyzed decalcified formalin-fixed paraffin-embedded (FFPE) samples of 18 bone tumors primarily diagnosed as SCOS by methylation profiling, fusion gene analysis, and immunohistochemistry.In eight cases, the diagnosis of SCOS was maintained, and in 10 cases it was changed into FDRCS, including three Ewing sarcomas (EWSR1FLI1 in two cases and no identified fusion gene in the third case), two sarcomas with BCOR alterations (KMT2DBCOR, CCNB3BCOR, respectively), three mesenchymal chondrosarcomas (HEY1NCOA2 in two cases and one case with insufficient RNA quality), and two sclerosing epithelioid fibrosarcomas (FUSCREBL3 and EWSR1 rearrangement, respectively).Histologically, SCOS usually possessed more pleomorphic cells in contrast to the FDRCS showing mainly monomorphic cellular features. However, osteoid was seen in the latter tumors as well, often associated with slight pleomorphism. Also, the immunohistochemical profile (CD99, SATB2, and BCOR) overlapped.Clinically and radiologically, similarities between SCOS and FDRCS were observed, with by imaging only minimal presence or lack of (mineralized) osteoid in most of the SCOSs.In conclusion, discrimination of SCOS, epigenetically related to COS, versus FDRCS of bone can be challenging but is important due to different biology and therefore therapeutic strategies. Methylation profiling is a reliable and robust diagnostic test especially on decalcified FFPE material. Subsequent fusion gene analysis and/or use of specific immunohistochemical surrogate markers can be used to substantiate the diagnosis.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sarcoma / Neoplasias Óseas / Osteosarcoma / Sarcoma de Células Pequeñas Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sarcoma / Neoplasias Óseas / Osteosarcoma / Sarcoma de Células Pequeñas Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article